The newly discovered vaccine ‘Dostarlimab’ has cured rectal cancer for the first time in history. Dostarlimab is a medicine made in a lab that functions as a surrogate for antibodies in the human body, according to specialists.
The trial experiment was conducted with 18 patients who took medicine for six months in a limited clinical trial done by Memorial Sloan Kettering Cancer Center. The participants of the trial didn’t expose to any serious side effects.
The new vaccine allows the body’s immune system to identify and destroy cancer cells naturally. Such drugs are known as ‘checkpoint inhibitors’.
After a successful trial for six months, the malignancy is undetectable by either of the following methods - physical examination, endoscopy, positron emission tomography or PET scans or MRI scans. With this, the researchers have concluded that the vaccine Dostarlimab has the potential to cure one of the most lethal tumors.
Cancer is one of the leading causes of death worldwide. It accounted for about 10 million deaths in 2020 i.e. one in six deaths are related to cancer. In the year 2020, the various types of leading cancers were Breast cancer (2.26 million cases), lung cancer (2.21 million cases), colon and rectum cancer patients (1.93 million).